Differential Cytokine Regulation of PAI-1 Gene Expression Between Human Umbilical and Subcutaneous Fat-Derived Microvascular Endothelial Cells

References

• Loskutoff D. J., Sawdey M., Mimuro J. Type-1 plasminogen activator inhibitor. Prog. Hemostasis. Thromb 1989; 9: 87–115
   PubMedGoogle Scholar
• Collen D. On the regulation and control of fibrinolysis. Thromb. Haemost 1980; 43: 77–89
   PubMed Web of Science ®Google Scholar
• Sprengers E. D., Kluft C. Plasminogen activator inhibitors. Blood 1987; 69: 381–387
   PubMed Web of Science ®Google Scholar
• Beers W. H., Strickland S., Reich E. Ovarian plasminogen activator: Relationship to ovulation and hormonal regulation. Cell 1975; 6: 387–394
   PubMed Web of Science ®Google Scholar
• Dano K., Andreasen P. A., Grondahl-Hansen J., Kristensen P., Nielsen L. S., Skriver L. Plasminogen activators, tissue degradation and cancer. Adv. Cancer Res 1985; 44: 139–266
   PubMed Web of Science ®Google Scholar
• Ossowski L., Reich E. Antibodies to plasminogen activator inhibit tumor metastasis. Cell 1983; 35: 611–619
   PubMed Web of Science ®Google Scholar
• Strickland S., Reich E., Sherman M. I. Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm. Cell 1976; 9: 231–240
   PubMed Web of Science ®Google Scholar
• Van Mourik J. A., Lawrence D. A., Loskutoff D. J. Purification of an inhibitor of plasminogen activator (inactivator) synthesized by endothelial cells. J. Biol. Chem 1984; 259: 14914–14921
   PubMed Web of Science ®Google Scholar
• Mawatari M., Kohno K., Mizoguchi H., Matsuda T., Kuni-ichi Asoh, VanDamme J., Welgus H. G., Kuwano M. Effects of tumor necrosis factor and epidermal growth factor on cell morphology, cell surface receptors and the production of tissue inhibitor of metalloproteinases and IL6 in human microvascular endothelial cells. J. Immunol 1989; 143: 1619–1627
   PubMed Web of Science ®Google Scholar
• Mawatari M., Okamura K., Matsuda T., Hamanaka R., Mizoguchi H., Higashio K., Kohno K., Kuwano M. Tumor necrosis factor and epidermal growth factor modulate migration of human microvascular endothelial cells and production of tissue-type plasminogen activator and its inhibitor. Exp. Cell. Res 1991; 192: 574–580
   PubMed Web of Science ®Google Scholar
• Wiman B., Almquist A., Sigurdardottir O., Lindahl T. Plasminogen activator inhibitor 1 (PAI-1) is bound to vitronectin in plasma. FEBS Lett 1988; 242: 125–128
   PubMed Web of Science ®Google Scholar
• Declerck P., De Mol M., Alessi M-C., Baudner S., Paques E-P., Preissner K. T., Muller-Berghaus G., Collen D. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma; identification as a multimeric form of s protein (vitronectin). J. Biol. Chem 1988; 263: 15454–15461
   PubMed Web of Science ®Google Scholar
• Ciambrone G. J., McKeown-Longo P. J. Vitronectin regulates the synthesis and localization of urokinase-type plasminogen activator in HT-1080 cells. J. Biol. Chem 1992; 267: 13617–13622
   PubMed Web of Science ®Google Scholar
• Wagner O. F., de Vries C., Hohmann C., Veerman H., Pannekoek H. Interaction between plasminogen activator type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA): Binding of tPA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of tPA. J. Clin. Invest 1989; 84: 647–655
   PubMed Web of Science ®Google Scholar
• Ehrlich H. J., Keijer J., Preissner K. T., Klein G. R., Pannekoek H. Functional interaction of plasminogen activator inhibitor type 1 (PAI-1) and heparin. Biochemistry 1991; 30: 1021–1028
   PubMed Web of Science ®Google Scholar
• Juhan-Vague I., Ailluad M. F., De Cock F., Philip-Joet C., Arnaud C., Serradimigni A., Collen D. The fast-acting inhibitor of tissue-type plasminogen activator is an acute phase reactant protein. Progress in fibrinolysis, J. F. Davidson, M. B. Donati, S. Coccheri. Edinburgh, Churchill Livingstone. 1985; vol 7: 146–153
   Google Scholar
• Kluft C., Verheijen J. H., Jie A. F. H., Rijken D. C., Preston F. E., Sue-Ling H. M., Jespersen J., Aasen A. O. The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand. J. Clin. Lab. Invest 1985; 45: 605–610
   PubMed Web of Science ®Google Scholar
• Heinrich P. C., Castell J. V., Andus T. Interleukin-6 and the acute phase response. Biochem. J 1990; 265: 621–636
   PubMed Web of Science ®Google Scholar
• Baumann H., Prowse K. R., Marinkovic S., Won F. -A., Jahreis J. P. Stimulation of hepatic acute phase response by cytokines and glucocorticoids. Ann. NY. Acad. Sci 1989; 557: 280–296, ‘TAB’
   PubMed Web of Science ®Google Scholar
• Morrone G., Ciliberto G., Oliviero S., Arcone R., Dente L., Content J., Cortese R. Recombinant inter-leukin 6 regulates the transcriptional activation of a set of human acute phase genes. J. Biol. Chem 1988; 263: 12554–12558
   PubMed Web of Science ®Google Scholar
• Kunz D., Zimmerman R., Heisig M., Heinrich P. C. Identification of the promoter sequences involved in the interleukin-6 dependent expression of the α2-macroglobulin gene. Nucl. Acids. Res 1989; 17: 1121–1138
   PubMed Web of Science ®Google Scholar
• Kaski-Oja J., Koli K., Lohi J., Laiho M. Growth factors in the regulation of plasminogen-plasmin system in tumor cells. Seminars in Thrombosis and Hemostasis 1991; 17: 231–239
   PubMed Web of Science ®Google Scholar
• Loskutoff D. J. Regulation of PAI-1 gene expression: Review. Fibrinolysis 1991; 5: 197–206
   Google Scholar
• Saksela O., Moscatell D., Rifkin D. B. Basis fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J. Cell. Biol 1987; 105: 957–963
   PubMed Web of Science ®Google Scholar
• Bevilacqua M. P., Schleef R. R., Gimbrone M. A., Jr., Loskutoff D. J. Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1. J. Clin. Invest 1986; 78: 587–591
   PubMed Web of Science ®Google Scholar
• Schleef R. R., Bevilacqua M. P., Sawdey M., Gimbrone M. A., Jr., Loskutoff D. J. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J. Biol. Chem 1988; 263: 5797–5803
   PubMed Web of Science ®Google Scholar
• Gelehrtet T. D., Sznycer-Laszuk R. Thrombin induction of plasminogen activator inhibitor in cultured human endothelial cells. J. Clin. Invest 1986; 77: 165–169
   PubMed Web of Science ®Google Scholar
• Crutchey D. J., Conanan L. B. Endotoxin induction of an inhibitor of plasminogen activator in bovine pulmonary artery endothelial cells. J. Biol. Chem 1986; 261: 154–159
   PubMed Web of Science ®Google Scholar
• Podor T. J., Jirik F. R., Loskutoff D. J., Carson D. A., Lotz M. Human endothelial cells produce IL-6. Lack of response to exogenous IL-6. Ann. NY. Acad. Sci 1989; 557: 374–387
   PubMed Web of Science ®Google Scholar
• Williams S. K., Jarrell B. E., Rose D. G., Pontell J., Kapelan B. A., Park P. K., Carter T. L. Human microvessel endothelial cell isolation and vascular graft sodding in the operating room. Ann. Vasc. Surg 1989; 3: 146–152
   PubMedGoogle Scholar
• Jaffe E. A. Culture and identification of large vessel endothelial cells. The Biology of Endothelial cells, E. A. Jaffe. Hingham, M. A., Martinus-Nijhoff 1984; 1
   Google Scholar
• Grant D. S., Lelkes P. I., Fukuda K., Kleinman H. K. Intracellular mechanisms involved in basement membrane induced blood vessel differentiation in vitro. In Vitro Cell Dev. Biol 1991; 27A: 327–336
   PubMedGoogle Scholar
• Lund L. R., Riccio A., Andreason P. A., Nielsen L. S., Kristensen P., Laiho M., Saksela O., Blasi F., Dano K. Transforming growth factor-B is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts. EMBO. J 1987; 6: 1281–1286
   PubMed Web of Science ®Google Scholar
• Sambrook J., Fritsh E. F., Maniatis T. Molecular cloning, a laboratory manual(2nd ed.). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 1989
   Google Scholar
• Marzluff W. F., Huang R. C. C. Transcription and translation, a practical approach, B. D. Hames, S. J. Higgins. Oxford, Washington, DC 1985; 89–129
   Google Scholar
• Greenberg M. E., Ziff E. B. Stimulation of 3T3 cells induces transcription of the C-FOS proto-oncogene. Nature 1984; 311: 433–438
   PubMed Web of Science ®Google Scholar
• Bosma P. J., Van den Berg E. A., Kooistra T. Human plasminogen activator inhibitor-1 gene. Promotor and structural gene nucleotide sequences. J. Biol. Chem 1988; 263: 9129–9141
   PubMed Web of Science ®Google Scholar
• Fey G. H., Hattori M., Northemann W., Abraham L. J., Baumann H., Braciak T. A., Fletcher R. C., Gauldie I., Lee F., Raymond M. F. Regulation of rat liver acute phase genes by interleukin 6 and production of hepatocyte stimulating factors by rat hepatoma cells. Ann. NY. Acad. Sci 1989; 557: 317–331
   PubMed Web of Science ®Google Scholar
• de Boer J. P., Abbink J. J., Brouwer M. C., Meijer D., Roem D., Voorn G. P., Lambers J. W. J., van Mourik J. A., Hack C. E. PAI-1 synthesis in the human hepatoma cell line Hep G2 is increased by cytokines-Evidence that the liver contributes to acute phase behaviour of PAI-1. Thromb. Haemost 1991; 65: 181–185
   PubMed Web of Science ®Google Scholar
• Podor T. J., Hirsh J., Gelehrter T. D., Torry D., Guigoz Y., Sierra F., Gauldie J. Type 1 plsmignogen activator inhibitor is not an acute phase reactant in rats. Lack of IL6 and hepatocyte-dependent synthesis. 1993; 150: 225–235
   Google Scholar
• Bergonzelli G. E., Kruithof E. K. O. Constitutive plasminogen activator inhibitor 1 (PAI-1) biosynthesis in human Hep G2 hepatoma cells IS maintained by an autocrine factor. Thromb. Haemostas 1991; 66: 222–225
   PubMed Web of Science ®Google Scholar
• Calderon T. M., Sherman J., Wilkerson H., Hatcher V. B., Berman J. W. Interleukin-6 Modulates c-sis (PDGF b subunit) Gene Expression in cultured Human Endothelial cells. Cellular Immuno 1992; 143: 118–126
   PubMed Web of Science ®Google Scholar
• Samad F., Bergtrom G., Amrani D. L. Regulation of plasminogen activation by interleukin-6 in human lung fibroblasts. Biochimica et Biophysica Acta 1993; 1221: 307–314
   Web of Science ®Google Scholar
• Laiho M., Saksela O., Andersen P. A., Keski-Oja J. Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured lung fibroblasts by transforming growth factor-B. J. Cell. Biol 1986a; 103: 2403–2410
   PubMed Web of Science ®Google Scholar
• Laiho M., Saksela O., Keski-Oja J. Transforming growth factor-β alters plasminogen activator activity in human skin fibroblasts. Exp. Cell. Res 1986b; 164: 399–407
   PubMed Web of Science ®Google Scholar